Spatial transcriptomics now spans two fundamentally different measurement strategies, and the choice between them shapes every downstream result a lab will generate. Sequencing-based platforms capture ...
A review in the Journal of Translational Medicine outlines how spatially resolved transcriptomics preserves tissue ...
Dublin, Nov. 20, 2024 (GLOBE NEWSWIRE) -- The "Spatial Genomics and Transcriptomics - Global Strategic Business Report" report has been added to ResearchAndMarkets.com's offering. The global market ...
A new conceptual roadmap guides life science researchers in designing spatial transcriptomics studies by aligning biological ...
Inflammatory bowel disease (IBD) is an umbrella term for Crohn's disease and ulcerative colitis, which both involve chronic inflammation in the digestive tract. IBD affects millions of people and ...
The rapid development of spatial transcriptomics (ST) technologies has greatly advanced the understanding of gene expression, tissue architecture, cellular composition, and disease mechanisms within ...
Illumina's spatial transcriptomics offering is slated to provide analyses of millions of cells per experiment across a 50 mm by 15 mm imaging area. (Pixabay) Illumina is raising the curtain on its ...
According to MarketsandMarketsâ„¢, the Spatial Genomics & Transcriptomics Market is projected to reach USD 1.23 billion by 2031 from USD 0.67 billion in 2026, at a CAGR of 12.9% during the forecast ...
Tissue preparation is the step in spatial transcriptomics that can determine whether an experiment succeeds or fails before the sample ever reaches the instrument. Getting fixation, sectioning, and ...
Spatial Genomics & Transcriptomics Market worth $1.23 billion by 2031 - Exclusive Report by MarketsandMarkets DELRAY BEACH, Fla., Nov. 9, 2026 /PRNewswire/ -- According to MarketsandMarkets, the Spati ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results